◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › M3V

MeVis Medical Solutions AG (M3V) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Health Information Services · DATA UPDATED 2026-08-16

MeVis Medical Solutions AG (M3V) operates in the Health Information Services industry and is headquartered in Bremen, Germany with about 127 employees. Its market capitalization is roughly €43 million. In the fiscal year ended 2025-09-30, M3V reported €16M in revenue and €3M in net income.

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe.

Interactive charts & full statements →

M3V Revenue & Earnings History — Annual Income Statement

Income statement2025-09-302024-09-302023-09-302022-09-302021-09-30
Total Revenue€16M€17M€17M€19M
Gross Profit€16M€16M€17M€18M
Operating Income (EBIT)€2M€4M€5M€6M
Net Income€3M€5M€5M€8M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

M3V Free Cash Flow History

Cash flow2025-09-302024-09-302023-09-302022-09-302021-09-30
Dividends Paid(€5M)(€5M)(€8M)(€4M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

M3V Balance Sheet History

Balance sheet2025-09-302024-09-302023-09-302022-09-302021-09-30
Total Assets€26M€26M€28M€31M
Total Liabilities€8M€9M€10M€13M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive M3V viewer.

Other Companies in Health Information Services

← M3B0All “M” companiesM5S →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.